archive_header_en_20251203154432269.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

A password that applicants have been notified of is required to view abstracts.<br>If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.<br>We will reply after confirming that you were a participant.<br>Thank you for your understanding.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

A strategy for “point mutation” of natural products: modular expeditious synthesis of middle-sized molecules and lead generation

The objective of this symposium is to discuss on the frontier researches in medicinal chemistry. Tremendous effort of human kind brought great progress for medicinal and pharmaceutical field, innovative treatment methods toward various kinds of disease are being developed every day. However, there are still many diseases that have no therapeutic approach even today. Against this background, it is important to share the advances and problems on medicinal and pharmaceutical fields with many researchers. Therefore, on this symposium, we have time to discuss on frontier researches by five researchers working on the development of methods for synthesizing bioactive compounds using own research methods. We would like to make it a place to share what kind of problems exist in the pharmaceutical field and what kind of viewpoints and directions symposiasts are promoting their research. We hope you can attend our symposium.

The Pharmaceutical Society of Japan

The 141st Annual Meeting of the Pharmaceutical Society of Japan (Hiroshima)

The 141st Annual Meeting of the Pharmaceutical Society of Japan (Hiroshima)

[S02-2]A strategy for “point mutation” of natural products: modular expeditious synthesis of middle-sized molecules and lead generation

Password required to view